WHO ICTRP trial

A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic…

NL-OMON41568 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting

Key facts

Trial ID NL-OMON41568
Public title A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection
Scientific title A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection - GS-US-248-0122: HCV SVR Registry
Primary sponsor Gilead Sciences
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Recruitment status Not Recruiting
Study type Observational invasive
Phase 2
Countries Australia;Austria;Bulgaria;Canada;Czechia;Estonia;France;Germany;Hungary;Italy;Netherlands ;New Zealand;Poland;Romania;Spain;Sweden;United Kingdom;United States of America
Conditions Hepatitis C infection liver disease;10019654;10047438;Hepatitis C infection;liver disease
Interventions ;Follow-up Registry;Hepatitis C Infection;Sustained Virologic Response
Registration date Apr 24, 2015
Target size 100
Secondary IDs 2011-000945-19;NL42225.018.12
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations